ID,Disease,Intervention,Population,Non-treated Pop,Treated Pop,Avg QAlY Gain,Tot QALY Gain,Cost
BP1,Hypertension,Thiazide diuretics,5000,3981,4485,1.31,7699,120
BP2,Hypertension,ACE Inhibitors,4000,3184,3654,1.49,7059,720
BP3,Hypertension,ARBs,10000,7962,9135,1.58,18489,720
BP4,Hypertension,Calcium Channel Blockers,12000,9554,10862,1.23,17809,600
BP5,Hypertension,Beta Blockers,4000,3184,3555,1.05,5049,600
LDL1,Hypercholesterolemia,Statins,14000,11672,12789,1.41,22061,540
LDL2,Hypercholesterolemia,Ezetimibe,1000,834,905,1.14,1295,1200
LDL3,Hypercholesterolemia,PCSK9,100,83,92,1.67,186,72000
